These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Abrogation of shedding of immunosuppressive neuroblastoma gangliosides. Li R; Ladisch S Cancer Res; 1996 Oct; 56(20):4602-5. PubMed ID: 8840970 [TBL] [Abstract][Full Text] [Related]
5. Effects of cell surface ganglioside sialidase inhibition on growth control and differentiation of human neuroblastoma cells. Kopitz J; Mühl C; Ehemann V; Lehmann C; Cantz M Eur J Cell Biol; 1997 May; 73(1):1-9. PubMed ID: 9174666 [TBL] [Abstract][Full Text] [Related]
6. [The immunological cellular phenotype and the prognosis in neuroblastoma in children]. Novikov AM; Blinov VM; Bukhny AF; Bassalyk LS Vopr Onkol; 1990; 36(6):693-7. PubMed ID: 2378089 [TBL] [Abstract][Full Text] [Related]
7. [Gangliosides as neurobiochemical markers]. De Luka SR; Vrbaski SR; Protić S Med Pregl; 1996; 49(9-10):377-83. PubMed ID: 8999294 [TBL] [Abstract][Full Text] [Related]
8. Targeting of ganglioside GD2 monoclonal antibody to neuroblastoma. Cheung NK; Neely JE; Landmeier B; Nelson D; Miraldi F J Nucl Med; 1987 Oct; 28(10):1577-83. PubMed ID: 3655911 [TBL] [Abstract][Full Text] [Related]
9. [Gangliosides as carbohydrate antigens associated with cancer and their possible use in tumor immunotherapy]. Horwacik I Przegl Lek; 2004; 61 Suppl 2():14-9. PubMed ID: 15686040 [TBL] [Abstract][Full Text] [Related]
11. Generation and characterization of dimeric small immunoproteins specific for neuroblastoma associated antigen GD2. Occhino M; Raffaghello L; Burrone O; Gambini C; Pistoia V; Corrias MV; Bestagno M Int J Mol Med; 2004 Sep; 14(3):383-8. PubMed ID: 15289889 [TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of human neuroblastoma. Prigione I; Corrias MV; Airoldi I; Raffaghello L; Morandi F; Bocca P; Cocco C; Ferrone S; Pistoia V Ann N Y Acad Sci; 2004 Dec; 1028():69-80. PubMed ID: 15650233 [TBL] [Abstract][Full Text] [Related]
13. Detection of microscopic disease: comparing histology, immunocytology, and RT-PCR of tyrosine hydroxylase, GAGE, and MAGE. Cheung IY; Cheung NK Med Pediatr Oncol; 2001 Jan; 36(1):210-2. PubMed ID: 11464887 [TBL] [Abstract][Full Text] [Related]
14. Expression of GD2 ganglioside by untreated primary human neuroblastomas. Wu ZL; Schwartz E; Seeger R; Ladisch S Cancer Res; 1986 Jan; 46(1):440-3. PubMed ID: 3940209 [TBL] [Abstract][Full Text] [Related]
15. The role of gangliosides in fenretinide-induced apoptosis of neuroblastoma. Lovat PE; Corazzari M; Di Sano F; Piacentini M; Redfern CP Cancer Lett; 2005 Oct; 228(1-2):105-10. PubMed ID: 15907365 [TBL] [Abstract][Full Text] [Related]
16. Gangliosides and related compounds as biological response modifiers. Nagai Y; Tsuji S; Sanai Y Adv Exp Med Biol; 1984; 174():183-93. PubMed ID: 6741730 [TBL] [Abstract][Full Text] [Related]
17. [Function of carbohydrate chains serving as tumor-markers and differentiation markers]. Muramatsu T Rinsho Byori; 1988 Nov; Spec No 79():27-36. PubMed ID: 3266884 [No Abstract] [Full Text] [Related]
18. Cellular immunity to human tumor-associated antigens. A review. Herberman RB Isr J Med Sci; 1973 Mar; 9(3):300-7. PubMed ID: 4575654 [No Abstract] [Full Text] [Related]